Side-by-side comparison of AI visibility scores, market position, and capabilities
Norwegian-American humanoid robotics. NEO robot at $20K pre-order. EQT deal for 10,000 units. Backed by OpenAI. Seeking $1B at $10B. ~$137M raised.
1X Technologies is a Norwegian-American humanoid robotics company developing general-purpose robots for real-world labor applications. Founded with backing from OpenAI, 1X operates at the intersection of AI and physical automation, pursuing the long-term vision of deploying humanoid robots at sufficient scale to address labor shortages across logistics, manufacturing, and services. The company has development offices in Norway and the United States, giving it access to deep robotics research talent and the US commercialization ecosystem.\n\nThe company's flagship product is the NEO humanoid robot, available for pre-order at $20,000 — a price point designed to bring humanoid robots within reach of commercial buyers rather than restricting them to research labs. 1X has signed a deal with EQT for 10,000 NEO units, one of the largest humanoid robot purchase commitments in the industry to date. The NEO is designed for bipedal locomotion in human-built environments, enabling deployment without facility modification. 1X differentiates through its focus on safe, controllable behavior and its close relationship with OpenAI for frontier AI capabilities.\n\n1X Technologies has raised approximately $137 million and is seeking $1 billion in new funding at a $10 billion valuation — a reflection of intense investor interest in humanoid robotics following high-profile moves by Tesla (Optimus), Figure, and Physical Intelligence. The EQT deployment agreement provides real-world validation that commercial customers are ready to commit capital to humanoid robot deployments, a milestone the industry has been anticipating.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.